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RESUMO 
 
A doença de Parkinson (DP) idiopática é uma doença neurodegenerativa que se 
manifesta com sintomas motores e não-motores, um deles, a disartria hipocinética, que 
se insere nos sintomas motores e é caracterizada por uma diminuída inteligibilidade do 
discurso. A inteligibilidade diz respeito à forma como o sinal de um falante pode ser ou 
não compreendido pelo seu interlocutor podendo variar consoante o interlocutor. 
Objetivo principal: compreender como a disartria é compreendida por diferentes 
grupos de ouvintes. O primary outcome foi definido como sendo o total de palavras 
corretamente compreendidas por cada participante de cada grupo. Métodos: foram 
recolhidas avaliações motoras e gravações áudio de Doentes de Parkinson com 
diferentes níveis de disartria. Posteriormente foi reunido um júri que incluiu terapeutas 
da fala, neurologistas, doentes de Parkinson, familiares de doentes de Parkinson e 
pessoas sem qualquer tipo de contacto com a doença. O júri realizou uma análise áudio-
percetiva das gravações procedendo a registos ortográficos de palavras e frases e análise 
de articulação, velocidade de fala, volume e inteligibilidade do discurso. Resultados: 
houve diferenças na percentagem de palavras corretamente compreendidas entre os 
grupos, tendo apresentado os neurologistas maior percentagem de acerto. Os piores 
scores em relação a velocidade, intensidade, articulação e compreensão de discurso 
foram associados a disartria severa. A articulação e a inteligibilidade do discurso foram 
parâmetros que mostraram uma tendência para diminuir a par com a gravidade da 
disartria, para todos os grupos de jurados, tendo sido mostrada também uma forte 
correlação entre os dois. Conclusões: o nível de inteligibilidade do discurso varia 
consoante os ouvintes e os grupos profissionais que trabalham com disartria diariamente 
têm mais facilidade em compreender o discurso dos Doentes de Parkinson, mesmo que 
os familiares que passam mais tempo com os doentes. Os defeitos de articulação são 
mais facilmente percecionados por qualquer interlocutor comparando com a intensidade 
ou velocidade do discurso, e a articulação parece estar correlacionada com a 
inteligibilidade do discurso. A percepção de ambas é mais difícil à medida que o grau de 
severidade de disartria evolui, para qualquer grupo de interlocutores. 
Palavras-Chave: inteligibilidade; disartria; análise áudio-perceptiva; Doença de 
Parkinson;  
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ABSTRACT 
 
Parkinson’s disease (PD) is a neurodegenerative disease with motor and nonmotor 
symptoms, one of them, hypokinetic dysarthria, is a motor symptom characterized by 
diminished speech intelligibility. Intelligibility concerns how a speaker's signal can be 
understood by his / her interlocutor and may be affected by factors intrinsic to the 
speaker but also by others associated with the listener. Improving speech intelligibility 
in PD is a therapeutic need.  
Main goal: To understand how dysarthric speech is understood by different groups of 
listeners. The primary outcome was defined as the total number of words correctly 
understood by each participant of each group  
Methods: Motor assessments and audio recordings of PD patients with different levels 
of dysarthria were collected. Subsequently, a panel was formed of speech therapists, 
neurologists, PD patients, relatives of PD patients and individuals without any contact 
with the disease. The panel conducted an audio-perceptual analysis of the recordings by 
orthographically transcribing words and sentences and performing articulation, speech 
velocity, volume and speech intelligibility analyses.  
Results: There were differences in the percentage of words correctly understood 
between groups. Neurologists obtained the highest percentage. The worst results in 
terms of velocity, intensity, articulation and discourse comprehensibility were associated 
with severe dysarthria. The articulation and the discourse comprehensibility were 
parameters that showed a tendency to decrease with the severity of dysarthria, for all 
panel groups, and a strong correlation was also shown between the two.  
Conclusions: The level of speech intelligibility varies according to the listeners. The 
professional groups working with dysarthria on a daily basis are the most likely to 
understand the discourse of PD patients, even when compared with the family members 
who spend the most time with the patients. Articulation defects are more easily 
perceived by all interlocutors compared to the intensity or speed of discourse, and 
articulation seems to be correlated with speech intelligibility. The perception of both is 
more difficult as the degree of severity of dysarthria evolves, for all groups of 
interlocutors.  
Key Words: Intelligibility; dysarthria; audio-perceptive analysis; Parkinson’s disease. 
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INTRODUCTION 
Parkinson’s Disease 
 
The International Parkinson and Movement Disorder Society (MDS) defines 
Parkinson's disease (PD) as a neurodegenerative movement disorder, with predominant 
lesions in the basal ganglia, mainly in the substantia nigra, with a deficit of dopamine.1,2 
PD was first described by Dr. James Parkinson in 1817 and is generally considered a 
progressive neurodegenerative disease with motor, nonmotor, and behavioural 
symptoms being among the most prevalent neurodegenerative conditions.3,4 
The worldwide prevalence of PD varies widely.4 In Portugal, a 1994 study identified a 
prevalence of 130/100.0005 and currently the estimated total number of cases of PD for 
the Portuguese population is 180/100 000 inhabitants.6 
The cardinal motor symptoms of the disease are: bradykinesia, rigidity, rest tremor, 
and postural instability.7 They are linked to the degeneration of dopaminergic neurons in 
the substantia nigra pars compacta (SNpc).1,8 The non-motor symptoms include mood 
changes, cognitive changes, orthostatic hypotension, constipation and early satiety, 
hyperhidrosis, seborrhea, urinary urgency and incontinence, sexual dysfunction, loss of 
sense of smell, sleep disorders, insomnia and excessive daytime sleepiness (rapid eye 
movement behavioural disorder or active dreaming, dream enactment, involuntary 
movements and vocalizations during sleep, restless leg syndrome/periodic limb 
movement disorder; fatigue), and sensory problems (pain, tightness, tingling, burning).7 
These are related to the degeneration of other neuronal groups (e.g., serotoninergic 
neurons of the raphe nucleus, noradrenergic neurons of the locus ceruleus or cholinergic 
neurons of the nucleus basalis of Meynert).1,8 
Pathophysiologically, PD is classified as a synucleinopathy.9,10 α-synuclein is an 
abundant neuronal protein that is highly enriched in presynaptic nerve 
terminals.11 Accumulation of misfolded oligomers and larger aggregates of α-synuclein 
define multiple neurodegenerative diseases including PD, but the mechanisms by which 
α-synuclein acts in neurodegeneration remains mostly unknown.9 
The gradual loss of neurons results in a slow progression of symptoms and signs.12 
Nevertheless, PD is considered as highly heterogeneous in the way that the clinical 
signs manifest and the rate of progression of the disease.
13
 
There is no specific test or method for PD diagnosis and this presents a challenge 
because early symptoms can mimic those typical of normal aging or of other neurologic 
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diseases.14,15 Therefore, diagnosis is based on anamnesis, imaging tests, the response to 
medications and the clinical criteria are based on the relative sensitivity and specificity 
of clinical signs.16 Currently, a variety of imaging techniques such as magnetic 
resonance imaging, diffusion tensor imaging, positron emission tomography, single-
photon emission computed tomography and transcranial sonography may be used in the 
assessment of various parkinsonian syndromes.17 For the clinical diagnosis of PD, the 
MDS reviewed the diagnostic criteria in 2015 and currently they use a two-step process: 
first, parkinsonism is defined (bradykinesia in combination with either rest tremor, 
rigidity, or both) and the criteria then define whether this parkinsonism is attributable to 
PD.18 Before 2015 the UK Parkinson’s Disease Society Brain Bank Clinical Diagnostic 
Criteria were widely used.19 
Drug therapies have tended to focus on replacing dopamine – the major-medical 
approach to treating PD - or addressing specific symptoms associated with the 
disease.2,8 Levodopa is still today the reference among anti-Parkinson’s therapies.20 
Classifications of anti-PD medications include anticholinergics, dopamine agonists, 
amantadine, monoamine oxidase B (MAO-B) inhibitors, levodopa-carbidopa, and 
Catechol-o-methyl transferase inhibitors.21 
 
Hypokinetic Dysarthria 
 
Speech disorders were first mentioned in the description of PD by James Parkinson. 
He stated that “speech was slow, jerky and short of phrase… jolted out as it were, like 
an inexperienced rider on horseback, when the animal is trotting”.22 These features are 
attributed to hypokinetic dysarthria. 
Dysarthria refers to a group of neurologic motor speech disorders, resulting from 
central and/or peripheral nervous system abnormalities and hypokinetic dysarthria is the 
typical speech disorder that presents in PD patients.23–25 
Dysarthria classification is based on perceptual characteristics of speech and 
corroborated by the underlying neuropathology26, but in general they are characterised 
by slow, weak, imprecise or uncoordinated movements of the muscles responsible for 
speech .27 According to some authors, cranial motor deficits in the form of a hypokinetic 
dysarthria (and dysphagia) are reported in 90% of PD patients and there are studies that 
show an association of these with significant reductions in quality of life, social 
interactions and mental well-being.23,25,28,29  
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Hypokinetic dysarthria in PD typically shows reduced vocal loudness, flattened 
loudness and pitch inflections, poor voice quality, variable and frequently increased 
speech rate, inappropriate silences and breathiness.
30–32
 The combination of rigidity and 
bradykinesia have repercussions in respiratory, musculoskeletal and stomatognathic 
systems.33 Ultimately, respiration, phonation, articulation, resonance, and prosody are 
impaired in PD, these are the five subsystems responsible for speech and voice 
production.34–36  
One shared characteristic in all dysarthrias is reduced speech intelligibility.23,34 
Reduced intelligibility can have a critical impact on communication abilities and may 
limit vocational, educational, and social participation which can greatly interfere with 
quality of life that can be greatly diminished.34 
 
Voice and Speech Subsystems 
Respiration 
 
The respiratory cycle is composed of two phases
37
:  
 Inspiration: active phenomenon that implies the contraction of the diaphragm 
and accessory breathing muscles (external intercostals, anterior serrate, 
sternocleidomastoid, and scalene muscles) leading to expansion of the thoracic cage, 
creating a negative pressure allowing the lungs to expand; 
 Expiration: passive phenomenon where the relaxation of the inspiratory muscles 
allows the elastic recoil of the lungs and the thoracic cage, creating a positive pressure 
that expels the air out of the lungs. 
Respiratory dysfunction which can strongly contribute to hypokinetic dysarthria, is a 
significant cause of morbidity and mortality in PD and is associated with increasing 
severity of PD.
38–41
 It may be characterized by a hyporespiratory pattern that may result 
from rigidity - irregular activation of agonist/antagonist muscles or by akinesia of the 
intercostal muscles leading to a limited movement of the thoracic cage.
36,40
 A study 
from 2010 divided respiratory dysfunction in PD into five subtypes: upper airway 
obstruction (UAO), restrictive disorders, complications of medication intake, 
complications of medication withdrawal, and aspiration pneumonia.
37
 Studies show that 
UAO contributes to 70% of hypophonia in PD, attributed to rigidity and fatigability of 
the thyroarytenoid muscles during vocalization.37,42 
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Resonance  
 
Hypernasality may result from abnormalities in the involved structures, and in this 
case is called velopharyngeal insufficiency (e.g., cleft palate) or from distorted 
neuromuscular control of the levator veli palatini muscle and velopharyngeal seal, 
called velopharyngeal incompetence (e.g., neurodegenerative diseases like PD).
43
 In PD, 
because of the rigidity and bradykinesia, there are limitations of certain movements of 
the involved muscles, e.g., reduction of the opening of the mouth, that may interfere 
with patients resonance.30,36 Hypernasality results from a velopharyngeal impairment 
and has been reported in PD.26 It could be defined as “the presence of inappropriate air 
leakage through the nasal cavity during phonation”.26,44 Hypernasality in PD is not often 
perceived by the listener because of so many other dysarthria manifestations; studies 
have revealed that it was only perceptually detected in 10% to 30% of patients.
26,45
 
 
Articulation 
 
Imprecise vowel and consonant articulation is a common feature of dysarthria 
associated with PD which can be explained by a reduced amplitude of lips, tongue and 
jaw movements.16,30,46-47 Studies of physiologic measures of lip and tongue suggest 
slower rates of force and difficulty maintaining a given contraction.48 Vowels produced 
by individuals with dysarthria are characterized by articulatory undershoot (i.e., failure 
of the produced vowel to reach canonical formant frequencies – F1, F2), resulting in 
compressed or reduced working vowel space.49 F1 and F2 frequencies are mainly 
defined by the tongue position with the simplified ‘‘rule’’ that the F1 frequency is 
inversely related to the height of the tongue whereas the F2 frequency is directly related 
to the frontal tongue position.50 There is a restriction of articulatory gestures in PD and 
it is possible to note that on Triangular Vowel Space Area (Figure 1) assessed by 
plotting the F1 frequency as a function of F2 frequency for the vowels /a/, /i/, and /u/ in 
healthy controls and PD patients.47 Studies also show imprecise consonant articulation, 
usually those that require the most constriction like /p/, /b/ but also /s/, /f/, as well as 
/R/.51-52 
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Figure 1: Triangular vowel space area of a healthy speaker and from a PD patient (dotted triangle)47 
 
Speech rate is the amount of speech produced per time unit and can be measured by 
the amount of time an individual spends articulating and the amount of pause time.53 
Speech rate and rhythm are also compromised in PD which can be induced by complex 
dysfunction of planning, preparing and executing of motor speech sequences.54 Studies 
have shown that complex motor abnormalities seen in PD such as festination, hesitation, 
tremor, apraxias, akinesia, and dysprosody are also reflected in speech articulation.
55-56
 
One of the most disabling axial symptoms in PD is festination, a tendency to speed up 
when performing repetitive movements and this was reported in gait, handwriting, and 
also in speech.57  
 
Phonation  
 
Resulting from rigidity and bradykinesia typical of PD, laryngeal, respiratory and 
thyroarytenoid muscle movements are limited; it is described as a reduced amplitude of 
vocal fold movements, irregular vocal fold vibrations or low variety of vibration that 
may lead to glottal incompetence.30,36,55,58-59 Consequently, this leads to reduced voice 
volume (hypophonia), poor initiation of phonation and a harsh and breathy voice.55,58-59 
Another thing that may contribute to reduced voice volume is PD patients’ deficit in the 
perception of loudness.60 
 
Prosody  
 
Prosody consists of “distinct subdimensions, namely speech rhythm and velocity, 
articulation rate and speech to pause ratio, and speech intensity and pitch variation (the 
relative highness or lowness of a tone as perceived by the ear).
30,56
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Alterations in speech rate and pause time, and speech intensity and pitch variation are 
well described as being associated to PD.
56
 Inability to raise loudness of voice and vary 
pitch results in a low, monoloudness, monopitch and a hoarse voice.55 
 
Intelligibility of speech 
 
Intelligibility refers to how well a speaker’s acoustic signal can be accurately 
recovered by a listener or it can be defined as the degree to which the acoustic 
realization of one’s speech can be understood.34,61 However, it can be measured based 
solely on the sound signal, the so-called signal-dependent intelligibility or it can be 
based on the immediate acoustic signal and on cues from any other verbal (e.g. syntax, 
semantics) or non-verbal sources (e.g., facial expression, gesture, broader contextual 
setting).62-63  Signal-dependent intelligibility involves neither semantic/ syntactic 
context, nor visual aspects of communication like. gestures, but is purely determined by 
the performance of the speech production system.61 
Typically, this signal-dependent intelligibility is measure by having listeners 
orthographically transcribe words or sentences that the speaker had read and a score is 
calculated dividing the number of words understood and the total number of words 
spoken.63 In this process, it is important to note that there are two stakeholders: a 
speaker who produces an acoustic signal for the purposes of conveying linguistic 
content and a listener who receives the signal and interprets the linguistic content.64 
Thus, both production-related variables associated with the speaker and perception-
related variables associated with the listener play key roles in intelligibility.64 In a 
clinical context, the speech therapist listens to and rates the patient’s utterances and this 
rating is consequently subjective  as it is influenced by the listener’s familiarity with the 
patient’s voice, background and type of disorder and familiarity with the test material 
used.61 
Intelligibility may influence the termination or continuation of treatment and in severe 
cases, the consideration of augmentative and alternative communication systems.65 It is 
one of the main criteria used for the assessment of severity of speech disorders and 
improved intelligibility often constitutes a main goal of therapy.66 This is why a 
comprehensive understanding of the factors that influence intelligibility and its 
measurement is critical.65 Research has shown that intelligibility may be affected by 
many variables like: 
18 
 
 Message: 
o The speaker’s task e.g., saying words vs. sentences.64 
o Message predictability.67  
o Message length.65 
o Linguistic information e.g., real words vs. not real words.61 
o Visual-facial information.68 
 Environment/ Context: 
o The transmission system e.g., live voice vs. recorded voice.64 
o Contextual cues.69 
 Listener: 
o Familiarity.65 
o Listener experience.70 
 
Audio-perceptive analysis 
 
Speech perception and comprehension often involves the need to recognize degraded 
or unclear speech sounds.
71
 Speech comprehension comprises several hierarchically-
organized processing stages – lower-level acoustic and phonetic features are identified 
and (potentially) categorized into larger units (phonemes or syllables) to recognize 
familiar words and then access syntactic and semantic properties.
71
 The speed and 
accuracy of human speech comprehension when challenged by perceptual ambiguity is 
considered remarkable by Davis et al. as it seems to imply a neural hierarchy—temporal 
(left temporal cortex) and frontal regions (left frontal operculum; precentral gyrus; left 
anterior insula) with multiple processing pathways, activation of the superior temporal 
gyrus (STG) close to the primary auditory cortex—seen in functional neuroimaging 
data.
71–74
  
Evidence suggests that there are four top-down processes that contribute to speech 
perception: (1) perceptual grouping of speech sounds into a single coherent stream, (2) 
segmentation of speech into meaningful lexical units, (3) perceptual learning 
mechanisms by which distorted and degraded speech is perceived and understood and 
(4) mechanisms for perceiving variable forms of speech in a categorical fashion.
75
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According to the Davis et al. these top-down processes are influences that act on 
auditory, echoic representations of incoming speech, and there are influences that arise 
from the interface between speech perception and speech production.
75
 
A study from 2012 unequivocally demonstrated that clear speech can be processed 
even when ignored but degraded speech is processed depending on the listener’s state of 
attentiveness.
76
 
 
Aims and hypotheses 
 
The main planned objective of this study was to understand how dysarthric speech is 
understood by different groups of listeners. In particular we sought to examine auditory 
sensitivity to dysarthria by different interlocutors who are part of PD patients’ everyday 
life. The main hypothesis for this study was that different groups of listeners—speech 
and language therapists (SLTs), general population, relatives of PD patients, PD patients 
and neurologists,—would have different hit percentages in intelligibility tasks with 
words and sentences recorded from PD patients distinguished with different degrees of 
severity of dysarthria.  
The secondary objectives planned for this study were: 
1) To determine the inter-rater reliability within each group of listeners for the 
intelligibility tasks. 
2) To determine if SLTs have a higher inter-rater reliability in their ratings of 
dysarthric speech when compared with naive listeners. 
3) To determine whether listeners with greater interaction with PD (e.g., family 
members) have higher scores for the intelligibility tasks than the other groups. 
4) To determine whether PD patients can more easily understand the dysarthric 
speech associated with PD than the other groups. 
 
It was also hypothesized for this study that different groups of listeners would have 
different perception with regards to speech articulation, speech velocity, speech 
intensity or volume, and discourse comprehensibility, and this perception would differ 
according to dysarthria severity. The more severe the dysarthria, the worse the scores for 
each of these parameters. 
Therefore, the primary outcome was defined as the total number of words correctly 
understood by each participant in each group. Secondary outcomes included the total 
20 
 
number of sentences correctly understood by each participant in each group and the 
mean scores of parameters assessed for each conversation including velocity, intensity, 
articulation and discourse comprehensibility, for each level of dysarthria severity.  
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METHODS 
Design of the study 
 
This is an observational cross-sectional study.  
 
Participants 
 
A panel was formed to listen to the corpus or recordings and to orthographically 
transcribe and register the words and sentences and also perform a perceptive analysis 
through the conversation samples. The panel was constituted of different interlocutors 
who normally have a relevant role in the daily life of a PD patient with different levels 
of familiarity, knowledge and experience with dysarthric speech. 
The panel was composed of ten people from the general population who had no 
contact or experience with PD patients; 10 PD patients; 10 relatives; 10 neurologists and 
10 SLTs. Participants were recruited from hospitals, centers of rehabilitation medicine 
and the senior neurological campus. Inclusion and exclusion criteria of the - panel are 
summarized in table 1. Demographical data from the different groups and patients’ 
clinical problems are presented at tables 4 and 5. 
 
 Inclusion criteria Exclusion criteria 
General population 
 >=55 years; 
 Without any contact with PD 
patients, family, friends or acquaintances with 
the disease. 
Diagnosed hearing loss or any 
auditory deficit perceived by the 
participant that prevented collaboration 
in the study; 
Diagnosed cognitive deficit or any 
cognitive deficit perceived by the 
participant that prevented collaboration 
in the study. 
Parkinson’s disease patients 
 >=55 years; 
 >3 years since diagnosis; 
 Without relative cognitive 
impairment (MoCA). 
Parkinson’s disease relatives 
 >=55 years;  
 With daily contact with PD patient. 
Speech and language therapists  working experience with adults; 
 Without daily experience in 
assessment and intervention with PD patients. 
Neurologists  >5 years’ working experience with 
PD patients; 
 
Table 1: Inclusion and exclusion criteria of the jury panel 
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Materials 
Corpus – Selection and edition of audio-files recorded from PD patients 
 
First audio files were collected—words, sentences and conversation—of PD patients, 
and the associated demographic information, global motor assessment, level of 
dysarthria and speech characterization were made by an experienced SLT. All this 
information was from the “Fralusopark - Dysarthria in Parkinson’s Disease: Lusophony 
vs. Francophony Comparison”77 project database and was provided by JJ Ferreira Lab, 
Instituto de Medicina Molecular. All patients are native Portuguese speakers, right-
handed (Handedness Edinburgh test >80%)78, with a medical diagnosis of Idiopathic PD 
according to the UK Parkinson’s Disease Brain Bank Criteria79 for the diagnosis of 
idiopathic PD.  
From a database of sixty patients, ten PD patients who fulfilled the following criteria: 
male, >55 years old were included, three of these patients were diagnosed with mild 
dysarthria, three with moderate, three with severe dysarthria and one without dysarthria, 
the control subject. Only men were recruited in order to control the variable sex since 
there are differences between sexes in terms of speech characteristics which could 
influence the results. Speech diagnosis was performed by an SLT expertise in the 
assessment and treatment of acquired sensoriomotor speech disorders, using Frenchay 
Dysarthria Assessment – 2nd edition (FDA-2) protocol and a Clinical Global 
Impression (CGI) scale. The level of dysarthria severity level was analyzed by two other 
SLTs experienced in PD assessment and intervention. They performed an audio-
perceptive analysis of the recordings also using CGI. All the SLTs agreed on the 
inclusion of the patients who were included in the present study. Demographical data 
and total scores from speech and global motor assessment are presented in the results 
section as patients’ current clinical problems. 
The audio-files selected from each patient include 5 single words and 5 phrases 
randomly chosen from a set of 12 words and phrases read by the patients. These words 
and phrases were also randomly chosen from a set of 109 words and 60 phrases 
available  – illustrated in figure 2. They also included twenty seconds of a conversation 
cut from a two-minute conversation between the PD patient and the SLT in a way that 
the SLT does not interfere in the sample selected. A total of 50 different words, 50 
different sentences and 10 conversation samples were finally selected. These words and 
sentences were part of the intelligibility tasks of FDA-2 that include a group of samples 
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with strong correlations in terms of distribution of frequency of phonemes, word length 
and type of syllabic structure involved. All patients were recorded in a quiet room with 
special speech recording equipment (Marantz PMD661 MKII recorder). Using Audacity 
software, the fifty words were put together in one single audio-file with silent intervals 
in between each word. In another single audio file the sentences were put together with 
a silent interval in between each. This time intervals were established so that the listener 
had time to write down the word.  
 
Figure 2: Process of selecting words and sentences for each patient 
 
Information Sheet 
 
An information sheet was prepared for panel members. This sheet collected 
information including: research project title, purpose, proceedings, possible benefits, 
predictable physical risks, voluntary form of participation and right to leave the study, 
the use of data, and contact details. The participants had access to this information sheet 
before agreeing to participate in the study. If, after reading all this information and 
taking all doubts into consideration, the participant agreed to proceed, an informed 
consent was presented in order to obtain his/her consent. ANNEXE I 
The researcher was present during orthographic annotations in order to make sure that 
each file (word or sentence) was only reproduced once, to ensure the intelligibility of 
the participants’ writing and to make sure that none of the parameters to be evaluated 
was forgotten. 
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Informed Consent 
 
The informed consent sheet explained that the participant was part of a research 
project title, and informed on the purpose, proceedings, possible benefits, predictable 
physical risks, voluntary form of participation and right to leave the study, the use of 
data and contact details. To confirm acceptance, the participant signed  the form as did 
the investigator. The original document remains with the investigator and a duplicate 
with the participant. ANNEXE II 
 
Case Report Form (CRF)  
 
A CRF was created to be completed by the investigator with demographic data of the 
panel, and blank spaces provided so that the panel members could transcribe the words 
(50 blank spaces) and the sentences (50 blank spaces). Ten tables were also included 
that consisted of four parameters each—speech velocity, intensity, articulation and 
speech comprehension—and 5-Likert type options per parameter (two options below 
the normal one, the normal option and two more above), to select according to the 
perceptual analysis of the conversation – ANNEXE III.  
 
Proceedings 
 
First the panel members were informed about dysarthria and intelligibility of speech 
concepts by reading the information sheet. The proceedings were described and if the 
participant wished to continue, they signed the informed consent. The audio files–words 
and sentences—were presented separately, only once, via headphones. Between each 
word there was a four second interval and between each sentence a seven second 
interval. Extra time for intervals was dictated by the transcription pace of the listeners 
or, other reasons: if a panel member asked, if the panel member paused to think about 
what had been heard before writing it down, if a panel member was tired; if for some 
reason a panel member asked. The investigator controlled the playing of audio-files and 
was prepared to pause if necessary. The panel members were instructed to write down 
what they heard in capital letters so that the investigator could understand what was 
written down.  
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Then, before the conversation audio/perceptive analysis of four parameters that the 
panel assessed—speech velocity, intensity, articulation and speech comprehension—
were described in the CRF and examples were given for each one. The proceedings 
were described. Each table had the four parameter listed and each parameter had 5 
options to characterize the conversation sample: 
 Speech velocity: very slow (0), slow (1), normal/ adequate (2), fast (3), very fast (4) 
 Intensity: very low (0), low (1), normal/ adequate (2), loud (3), very loud (4) 
 Articulation: very bad (0), bad (1), normal/ adequate (2), good (3), very good (4) 
 Understanding speech: very difficult (0), difficult (1), normal/ adequate (2), easy (3), 
very easy (4). 
For statistical analysis purposes, each classification corresponded to a value reported 
between parentheses. The conversation was played once. If the panel member 
considered part of the conversation with one characteristic and another part differently, 
it was possible to select two or more options for each parameter.  
 
Statistical Analysis 
Characterization of PD patients’ recordings was reported by describing the following 
variables: age (mean and standard deviation), years of education (mean and standard 
deviation), place of birth and living place since when, first symptoms and diagnosis 
data, total scores of FDA-2 (mean ± SD, max and min.) and MDS-UPDRS (mean ± SD, 
max and min.). The clinical problems and voice symptoms were also reported and 
percentage values presented. 
Characterization of the participants from the panel was reported by calculating the 
mean and standard deviation for the quantitative variables and counts and percentages 
for categorical variables.  
The total of words correctly understood in the intelligibility task by all participants 
was calculated and presented by hit percentages, and means and standard deviations per 
group. Whether the data followed a normal distribution for all groups was verified with 
a Shapiro Wilk test and homogeneity of the variances with a Levene’s Test. For the 
comparison of results of correct orthographic transcription of words between the 
groupsa Kruskall-Wallis test was performed, and because the the homogeneity of the 
variance (Levene’s test) was not verified, a non-parametric test was chosen. The test 
was adjusted for tied ranks and follow-up tests were conducted to evaluate pairwise 
differences among the 5 groups and the effect size for pairwise comparisons was 
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presented with statistically significant values. The same methodology was followed to 
study the correct orthographic transcription of sentences .  
To examine inter-rater reliability—considered the measurement of the extent to which 
raters assign the same score to the same variable—within each group, the percent 
agreement was calculated, and which consisted of the number of agreement scores 
divided by the total number of scores.
80
 For this it “correct” or “not correct” transcribed 
words or sentences were considered—a perfect match between all words and phonemes 
spoken and written by the panel.  
The hit percentage of words and sentences was calculated per dysarthria severity level 
and per group.  
The audio-perceptive analysis of speech samples was also examined and the four 
variables classified—articulation, speech velocity, intensity and ease of 
comprehension—mean values ± SD were calculated in relation to the level of dysarthria 
and also per group.  
All descriptive and inferential results were obtained using SPSS ® Software, version 
20.0 (SPSS, Inc., Chicago, IL) and p-values less than 0.05 were considered significant. 
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RESULTS 
Characterization of PD patients recorded for material purposes 
 
Subjec
t Number 
Ag
e 
Place 
of Birth 
Living 
Place 
(since) 
Years of 
Education 
First 
Simptoms 
Date of 
the 
Diagnosis 
FDA-
2 
Scores 
MDS-
UPDRS 
Scores 
Level of 
Dysarthria 
1 59 
Lisboa 
Lisboa 
(always) 
11 2010 2012 98 113 Normal 
2 75 Alfeiri
a 
Alfreiria 
(always) 
2 1998 2000 90 193 Ligeiro 
3 75 
Torres 
Vedras 
Torres 
Vedras 
(always) 
5 2005 2005 85,5 217 Ligeiro 
4 67 
Lisboa 
Lisboa 
(always) 
10 2013 2014 97 148 Ligeiro 
5 72 
Elvas 
Lisboa 
(1964) 
4 2010 2012 89,5 151 Moderado 
6 61 Proenç
a a Nova 
Lisboa 
(1972) 
4 2000 2002 85 169 Moderado 
7 79 Vale 
de 
Cambra 
Lisboa 
(1962) 18 2000 2000 81 181 Moderado 
8 72 Viana 
do 
castelo 
Lisboa 
(1968) 4 2005 2005 84,5 225 Grave 
9 78 
Torres 
Vedras 
Torres 
Vedras 
(since ever) 
16 ND 2000 57 182 Grave 
10 84 
Lisboa 
Lisboa 
(>30 years) 
14 ND 2002 72,5 197 Grave 
Mean 
± SD 
72.
2 ± 
7.9 
 
 
8.8 ± 5.8  
  
84.0 
± 12.0 
177.6 ± 
33.8 
 
Table 2: Demographical data and total scores from speech and global motor assessment of PD patients that were recorded for 
material purposes. ND meaning “no data”. 
 
Subject 
Number 
Motor 
Fluctuations 
(N%) 
Dyskinesia 
(N%) 
Postural 
Instability (N%) 
Mild Cognitive 
Decline (N%) 
Decreased voice 
volume (N%) 
Slurred 
Voice (N%) 
1 - - - + + - 
2 + + + + + + 
3 - - - + - + 
4 + - + - + - 
5 - - - - + - 
6 + - + + + - 
7 + + - + - + 
8 + - + - - - 
9 - - + + + + 
10 - - + + + - 
Total 5 (50%) 2 (20%) 6 (60%) 7 (70%) 7 (70%) 4 (40%) 
Table 3: current clinical problems and voice symptoms of PD patients that were recorded for material purposes. + means it’s 
present; - means it’s not present 
 
This sample was composed by ten men who had a mean age of 72.2 years ± 7.9 SD 
and 8.8 years of education ± 5.8 SD, all of them living in the Lisbon district for at least 
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30 years. Regarding symptoms, 8 individuals with first PD symptoms a maximum 2 
years prior to diagnosis, 2 individuals with no data; 3 with 17 years since PD diagnosis, 
2 individuals with 15 years of PD, 2 individuals with 12 years, and 2 with 5 years, 1 
with 3 years of PD.  The group had a mean FDA-2 score of 84.0 ± 12.0 SD, min 57 and 
max 98, with a mean MDS-UPDRS score of 177.6 ± 33.8 SD, min 113 and max 225. 
Data are presented in table 2.  
Regarding current clinical problems and voice symptoms, 7 patients had mild 
cognitive decline (assessed with MoCA) and perceived decreased voice volume, 6 
reported postural instability, 5 motor fluctuations, 4 slurred voice and 2 dyskinesia.  
Data are presented in table 3.  
The level of dysarthria was defined by 3 SLTs experienced in PD disease. All of them 
perceptually classified dysarthria severity levels, 2 by listening to the recordings, and 
one face-to-face who also performed a complete assessment including FDA-2 and 
MDS-UPDRS. These patients were classified the same by the 3 SLTs regarding severity 
levels of dysarthria.  
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Characterization of participants of panel 
 
 Age 
(years) 
(Mean ± 
SD) 
Education (N (%)) Gender 
(N (%)) 
Musical 
Studies 
Reading habits Knowledge 
of PD 0 1 2 3 4 5 6 1 2 3 4 
General Population 
(N=10) 
62.60±6.17 0 
 
5 
(50%) 
2 
(20%) 
3 (30%) 0 0 0 F: 6 (60%) 
M: 4 
(40%) 
Y: 1 (10%) 
N: 9 (90%) 
0 8 
(80%) 
1 
(10%) 
1 
(10%) 
Y: 8 (80%) 
N: 2 (20%) 
SLTs (N=10) 40.70±12.4
5 
0 0 0 0 0 7 
(70%) 
3 
(30%) 
F: 9 (90%) 
M: 1 
(10%) 
Y: 4 (40%) 
N: 6 (60%) 
0 7 
(70%) 
3 
(30%) 
0 Y: 10 (100%) 
N: 0 
Neurologists 
(N=10) 
43.90±7.42 0 0 0 0 0 6 
(60%) 
4 
(40%) 
F: 6 (60%) 
M: 4 
(40%) 
Y: 4 (40%) 
N: 6 (60%) 
0 7 
(70%) 
3 
(30%) 
0 Y: 10 (100%) 
N: 0 
Relatives (N=10) 65.00±6.04 0 2 
(20%) 
2 
(20%) 
0 2 
(20%) 
4 
(40%) 
0 F: 10 
(100%) 
M: 0 
Y: 1 (10%) 
N: 9 (90%) 
0 7 
(70%) 
3 
(30%) 
0 Y: 10 (100%) 
N: 0 
PD patients (N=12) 65.58±7.18 0 2 
(16.7%) 
1 
(8.3%) 
2 
(16.7%) 
1 
(8.3%) 
6 
(50%) 
0 F: 4 
(33.3%) 
M: 8 
(66.7%) 
Y: 7 
(58.3%) 
N: 5 
(41.7%) 
2 7 
(70%) 
3 
(30%) 
0 NA 
Table 4: Demographical data for jury panel groups. Education level: 0 – Preschool; 1 - Elementary school; 2 - Middle School; 3 - High School; 4 - Further education, not higher; 5 - Higher 
education; 6 - Doctoral degree. Reading habits: 1 – without; 2 – daily; 3 – weekly; 4 - monthly 
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The PD patient group was constituted of 12 participants while the other groups 
comprised 10 participants each. The mean age was between 40 and 45 for SLTs and 
neurologists, and between 62 and 66 years for the other groups. Concerning education, 
SLTs and neurologists were the groups with the most years of education, 70% of SLTs 
and 60% of neurologists with higher education—bachelor's or master's degree—and 
30% of SLTs and 40% of neurologists with a doctoral degree. Regarding sex, all groups 
except PD patients were constituted of a majority of women. None had undergone 
musical studies.  In all groups there were a higher percentage of participants with daily 
reading habits and knowledge of PD. Data are presented in table 4. 
 
 
Subject 
Number 
Motor 
Fluctuations 
(N%) 
Dyskinesia 
(N%) 
Freezing 
(N%) 
Hallucinations 
or delirium (N%) 
Decreased 
voice volume 
(N%) 
Slurred 
Voice (N%) 
Hoarseness 
(N%) 
MoCA 
scores 
1 + + - + + + - 24 
2 + - - + + - + 24 
3 - - - - + - + 27 
4 + - + - + + - 22 
5 - - - - + - + 21 
6 + + + + + + + 18 
7 - - - - - - + 26 
8 - - - - + - - 26 
9 - - - - + - + 29 
10 - - + - + + - 26 
11 + - - - + + - 27 
12 - - + - + - + 27 
Total  5 (41.7%) 2 (16.7%) 
4 
(33.3%) 
3 (25.0%) 11 (91.7%) 
5 
(41.7%) 
7 (58.3%) 
Mean 
24.8 ± 
3.1 SD 
Table 5: Parkinson’s disease patients group and their current clinical problems and voice symptoms. + means it’s present; - means 
it’s not present. MoCA scores ≤ 18 means  
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Regarding current clinical problems and voice symptoms of the PD patient group, 11 
patients reported decreased voice volume, 7 reported hoarseness, 5 motor fluctuations 
and slurred voice, 4 freezing, 3 hallucinations or delirium and 2 dyskinesia.  Data are 
presented in table 5. 
In terms of frequency of contact with PD patients, relatives spent a mean 6.7 ± 0.3 
days per week with PD patients and a mean of 14.3 ± 3.4 hours per day, while 
neurologists spent a mean 4.6 ± 0.3 days per week with PD patients and 4.4 ± 0.6 hours 
per day.  
In terms of professional experience, SLTs reported a mean 17.9 ± 3.9 years experience 
working with adults, and neurologists a mean of 16.4 ± 2.8 years working with 
movement disorders, particularly with PD.  
 
Primary outcome 
Differences in the hit percentage of dysarthric speech (words) between groups 
 
Table 6 presents the results established for the primary outcome—total number of 
words correctly understood by each participant of each group, the total hit percentage 
and the mean and standard deviation values for each group. 
 
 
Participa
nts 
General 
Population 
N = 10 
SLTs 
N = 10 
Neurologi
sts 
N = 10 
Relativ
es 
N = 10 
PD 
patients 
N = 12 
1 27 33 37 31 28 
2 29 30 36 28 22 
3 33 34 33 20 26 
4 31 31 39 37 22 
5 28 31 35 31 34 
6 33 37 35 28 20 
7 30 33 35 30 22 
8 31 33 33 33 31 
9 27 35 33 33 28 
10 32 37 36 32 35 
11     35 
12     34 
Total (%) 60.2% 66.8% 70.4% 60.6% 56.2% 
Mean ± 
SD 
30.1 ± 2.3 33.4 ± 
2.4 
35.2 ± 1.9 30.3 ± 
4.5 
28.1 ± 5.7 
Table 6: Total of words correctly understood in the intelligibility task by all participants’, hit percentages, means 
and standard deviations by group. Each participant heard a total of 50 words. 
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Results show differences in the hit percentage of words correctly understood between 
groups. In ascending order PD patients < general population < relatives < SLTS < 
neurologists.  
There was a normal distribution for all groups (Shapiro Wilk test: p-value > α) but the 
assumption of the homogeneity of the variances was not verified (Levene Test: p-value 
= 0.00 < α). A non-parametric Kruskal-Wallis test was conducted in order to evaluate 
overall differences among groups regarding median of total number of words correctly 
understood. The results of the analysis indicate that there are significant overall 
differences between the medians of the total words correctly annotated by the five 
groups, χ2 (4, N = 52) = 19.0, p = 0.00 with a mean rank of 18.7 for the general 
population, 33.2 for SLTs, 41.7 for neurologists, 22.0 for relatives and 18.7 for PD 
patients. The effect size was not high, η2= χ2/N-1, η2=0.4. Because the overall test is 
significant, pairwise comparisons among the 5 groups were completed and are presented 
in table 7. 
 
 SLTs Neurologists Relatives PD patients 
General 
Population 
χ2 (1, N = 20) = 6.6, 
p = .01 
η2=0.3 
χ2 (1, N = 20) = 12.9, p 
= .00 
η2=0.7 
χ2 (1, N = 20) = 0.3, p 
= .60 
χ2 (1, N = 22) = 0.4, p 
= .55 
SLTs  χ
2 (1, N = 20) = 2.6, p 
= .11 
χ2 (1, N = 20) = 3.5, p 
= .06 
χ2 (1, N = 22) = 3.962, 
p = .05 
Neurologists   χ
2 (1, N = 20) = 8.7, p 
= .00 
η2=0.5 
χ2 (1, N = 22) = 9.0, p 
= .00 
η2=0.4 
Relatives    χ
2 (1, N = 22) = .5, p 
= .49 
PD patients     
Table 7: Kruskall-Wallis pairwaise comparisons for medians of words correctly understood 
There are significant differences between the general population and SLTs, the general 
population and neurologists, neurologists and relatives, and neurologists and PD 
patients because, in these cases, p-value < α and the highest effect size was between 
neurologists and the general population, η2=0.678. 
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Secondary outcomes 
Differences in the hit percentage of dysarthric speech (sentences) between groups 
Table 8 presents the total number of sentences correctly understood by each participant 
of each group, the total hit percentage and the mean and standard deviations for each 
group. 
 
Participa
nts 
General 
Population 
SLTs Neurologi
sts 
Relati
ves 
PD 
patients 
1 31 34 37 31 36 
2 33 34 39 30 29 
3 37 39 42 25 27 
4 31 39 37 36 23 
5 39 35 38 37 35 
6 37 42 35 30 27 
7 26 34 38 35 23 
8 37 36 36 35 30 
9 32 36 36 37 35 
10 36 36 37 36 33 
11     33 
12     36 
Total (%) 67.8% 73.0
% 
75.0% 66.4% 61.2% 
Mean ± 
SD 
33.9±4.0 36.5±
2.7 
37.5±2.0 33.2±4
.0 
30.6±4.8 
Table 8: Total number of sentences correctly understood in the intelligibility task by all participants, hit 
percentages, means and standard deviations by group. Each participant heard a total of 50 words. 
 
Results show differences in the hit percentage of words correctly understood between 
groups. In ascending order PD patients < relatives < general population < SLTs < 
neurologists. 
There was a normal distribution for all groups (Shapiro Wilk test: p-value > α) but the 
assumption of the homogeneity of the variances was not verified (Levene Test: p-value 
= 0.00 < α). As for the words intelligibility task, a non-parametric Kruskal-Wallis test 
was conducted in order to evaluate overall differences among groups regarding the 
median of the total number of sentences correctly understood. The results of the analysis 
indicate that there are significant overall differences between the medians of the total 
sentences correctly annotated by the 5 groups, χ2 (4, N = 52) = 18.0, p = 0.00 with a 
mean rank of 26.0 for general population, 32.4 for SLTs, 39.9 for neurologists, 22.4 for 
relatives, and 14.3 for PD patients. The effect size was not high, η2= χ2/N-1, η2=0.4. 
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Because the overall test is significant, pairwise comparisons among the 5 groups were 
completed and are presented in table 9. 
 
 
 SLTs Neurologists Relatives PD patients 
General 
Population 
χ2 (1, N = 20) = 1.4, 
p = .24 
χ2 (1, N = 20) = 4.0, p 
= .05 
χ2 (1, N = 20) = 0.6, p 
= .45 
χ2 (1, N = 22) = 3.0, p 
= .09 
SLTs  χ
2 (1, N = 20) = 1.7, p 
= .19 
χ2 (1, N = 20) = 3.5, p 
= .06 
χ2 (1, N = 22) = 7.8, p 
= .01 
η2=0.4 
Neurologists   χ
2 (1, N = 20) = 7.612, 
p = .01 
η2=0.4 
χ2 (1, N = 22) = 13.318, 
p = .00 
η2=0.6 
Relatives    χ
2 (1, N = 22) = 2.3, p 
= .13 
PD patients     
Table 9: Kruskall-Wallis pairwaise comparisons of median number of sentences correctly understood 
 
There are significant median differences between SLTs and PD patients, neurologists 
and relatives, and neurologists and PD patients because, in these cases, p-value ≤ α and 
the highest effect size was between neurologists and PD patients η2=0.6. 
Comparing the hit percentages between words and sentences, there were higher values 
in all groups for correct orthographic transcription of sentences than words.  
 
Inter-rater reliability calculated by means of percent agreement  
 
 Group Interrater 
Reliability 
Words transcription 
Group Interrater 
Reliability 
Sentences transcription 
General 
Population 
0.9 0.8 
SLTs 0.9 0.9 
Neurologists 0.9 0.9 
Relatives 0.9 0.9 
PD patients 0.9 0.8 
Table 10: Interrater reliability for each group of judges 
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For the analyses of the interrater reliability, words and sentences were considered 
correct or not correct. The overall interrater reliability for each group was higher than 
0.8, which demonstrates an almost perfect agreement between the panel members in the 
correct orthographic transcription of words—the majority of the panel members 
correctly transcribed the same words.  
The same occurred for sentences, except for the PD patient group who demonstrated a 
strong agreement between the panel members of the correct orthographic transcription 
of sentences.  
Data are presented in table 10. 
 
Hit Percentage of words and sentences per level of dysarthria and per group 
 
 
Words Sentences 
Without 
Dysarthria 
Mild 
Dysarthria 
Moderate 
Dysarthria 
Severe 
Dysarthria 
Without 
Dysarthria 
Mild 
Dysarthria 
Moderate 
Dysarthria 
Severe 
Dysarthria 
N 
(%) 
97.7% 67.3% 78.3% 30.4% 82.7% 77.1% 77.6% 45.8% 
Table 11: percentage of words and sentences correctly transcribed per level of dysarthria. 
In descending order of hit percentage of words correctly transcribed per level of 
dysarthria, without dysarthria > moderate dysarthria > mild dysarthria > severe 
dysarthria. The same happened with sentences correctly transcribed. These results are 
shown in table 11.  
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Figure 3: percentage of words correctly transcribed per group and per level of dysarthria. Trend line represented in 
dashed lines.   
 
Looking at the data presented in figure 3 it is possible to notice a group that stands out 
because of their lower values in the orthographic transcription of words, this was the PD 
patient group, who had the lowest values for all degrees of dysarthria severity except for 
severe dysarthria where the relatives group had the lowest hit percentage.  The 
neurologist group had the highest values for mild and moderate dysarthria. The general 
population group presented the highest values for severe dysarthria, compared with 
other groups. SLTs presented a 100% correct transcription of words corresponding to 
the control participant, without dysarthria. 
All groups had lower scores for mild dysarthria less compared with moderate 
dysarthria.  For all groups, the hit percentage of correctly transcribed words was higher 
for people without dysarthria and lower for people with severe dysarthria. 
 
GP SLTs Neurologists Relatives PD patients
Without Dysarthria 98,0% 100,0% 98,0% 98,0% 93,3%
Mild 64,0% 77,3% 86,0% 68,7% 57,8%
Moderate 72,7% 83,3% 87,3% 75,3% 71,1%
Severe 30,7% 28,7% 28,0% 26,7% 27,2%
0,0%
10,0%
20,0%
30,0%
40,0%
50,0%
60,0%
70,0%
80,0%
90,0%
100,0%
Without Dysarthria Mild
Moderate Severe
Linear (Without Dysarthria)
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Figure 4: percentage of sentences correctly transcribed per group and per level of dysarthria. Trend line 
represented in dashed lines.   
Looking at the data presented in figure 4 it is possible to notice that the PD patient 
group had the lowest values for the orthographic transcription of sentences for all 
dysarthria severity levels, except for the control participant without dysarthria for which 
the relatives group had the lowest hit percentage, similarly to the intelligibility of words 
task. The SLT group had the highest values for mild and moderate dysarthria and had 
the same hit percentage of correct transcribed words for the control participant and mild 
dysarthria group. Neurologists presented the highest values for severe dysarthria, 
compared with the other groups and for the control participant, without dysarthria. 
Something that was not expected and can be observed when comparing the correct hit 
percentages of general population and relatives groups between mild and moderate 
dysarthria, is that for mild dysarthria these groups obtained lower scores. For all groups, 
the hit percentage of correctly transcribed words was lower for people with severe 
dysarthria. 
 
 
GP SLTs Neurologists Relatives PD patients
Without dysarthria 82,0% 84,0% 92,0% 74,0% 81,7%
Mild 76,0% 84,0% 82,0% 73,3% 71,1%
Moderate 79,3% 82,7% 81,3% 78,0% 68,3%
Severe 43,3% 48,7% 56,0% 45,3% 37,2%
0,0%
10,0%
20,0%
30,0%
40,0%
50,0%
60,0%
70,0%
80,0%
90,0%
100,0%
Without dysarthria Mild
Moderate Severe
Linear (Without dysarthria)
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Audio-perceptive analysis of conversation 
 
The audio-perceptive analysis of conversation included four parameters: velocity, 
intensity or volume, articulation of words, and discourse comprehensibility. The results 
analyzed per dysarthria severity level are shown in table 12.  
 
Dysarthria 
Parameters  
Without 
Mean±SD 
Mild 
Mean±SD 
Moderate 
Mean±SD 
Severe 
Mean±SD 
Velocity 1.9±0.5 1.8±0.8 1.4±0.8 1.4±1.1 
Intensity / Volume 2.2±0.4 2.1±0.7 2.1±0.7 1.1±1.0 
Articulation of 
words 
2.9±0,7 2.0±0,9 1.5±0.7 0.8±1.0 
Discourse 
comprehensibility 
2.9±0.8 2.4±0.9 2.1±0.8 0.9±1.0 
Table 12: Parameters assessed for each conversation versus levels of dysarthria. 
In terms of mean values, in descending order of parameters considered good or normal 
to parameters considered bad or very bad: without dysarthria > mild dysarthria > 
moderate dysarthria > severe dysarthria.  
Mean values for those without dysarthric conversation classified speech with normal 
velocity, between normal and loud intensity or volume, between normal and very good 
articulation of words and between normal and very easy understanding of speech.   
Mild dysarthria was classified with values between slow and fast velocity, low and 
loud intensity or volume, bad and good articulation of words, difficult and easy 
understanding of speech.  
Moderate dysarthria received values between slow and normal velocity, low and loud 
intensity or volume, bad and normal/adequate articulation, difficult and ease of 
understanding.  
Severe dysarthria was the only group of conversations receiving classifications of very 
slow velocity, very low intensity or volume, very bad articulation and very difficult to 
understand speech understanding.  
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Figure 5: Audio-perceptive analysis of conversation parameter velocity per level of dysarthria and by all jury 
groups 
 
In terms speech velocity of, SLTs were the most critical group of the control 
participant with a mean value of 1.5, which still corresponds to normal/adequate 
velocity as well as the perception of all the other panel groups. PD patients and general 
population groups were the most critical groups for mild dysarthria, but all groups 
presented mean values corresponding to normal/adequate velocity. Still, it is noteworthy 
that SLTs were more judgmental of the control participant than of the mild dysarthria 
group as far as this parameter was concerned. For moderate dysarthria, all groups 
presented mean values which corresponded to slow velocity, except for SLTs who had a 
mean score of 1.5 rounded to normal/adequate velocity of speech as in severe 
dysarthria, presenting a mean of 1.7. All the other panel groups’ mean values for severe 
dysarthria corresponded with slow velocity, the relatives group was the most 
judgmental.   
Data are presented in figure 5. 
 
GP SLTs Neurologists Relatives PD patients
Without dysarthria 2,00 1,50 2,00 2,25 2,04
Mild 1,63 1,80 1,75 1,88 1,64
Moderate 1,13 1,53 1,37 1,37 1,26
Severe 1,43 1,73 1,45 0,90 1,19
0,00
0,50
1,00
1,50
2,00
2,50
Without dysarthria Mild Moderate Severe
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Figure 7: Audio-perceptive analysis of conversation parameter articulation per level of dysarthria and by all 
jury groups 
GP SLTs Neurologists Relatives PD patients
Without dysarthria 2,70 2,90 3,10 3,00 2,58
Mild 2,00 2,30 1,58 2,05 1,82
Moderate 1,63 1,55 1,20 1,60 1,43
Severe 1,00 0,75 0,52 0,85 0,68
0,00
0,50
1,00
1,50
2,00
2,50
3,00
3,50
Without dysarthria Mild Moderate Severe
Figure 6: Audio-perceptive analysis of conversation parameter intensity per level of dysarthria and by 
all panel groups 
GP SLTs Neurologists Relatives PD patients
Without dysarthria 2,00 2,10 2,10 2,50 2,42
Mild 1,90 2,00 2,07 2,22 2,15
Moderate 1,85 2,23 2,03 2,03 1,99
Severe 1,10 1,10 0,92 1,03 1,14
0,00
0,50
1,00
1,50
2,00
2,50
3,00
Without dysarthria Mild Moderate Severe
 
 
 
 
 
 
 
 
 
 
 
 
 
For speech intensity , it is possible to look at the data in figure 6. Relatives were the 
only group who considered the control participant to have a high volume. All the other 
groups’ mean values that corresponded to normal/adequate volume or intensity. For 
mild and also for moderate dysarthria, all panel groups had mean values that 
corresponded with normal/adequate intensity or volume with the general population 
being the most critical group, Relatives and SLTs were the least judgmental for mild and 
moderate dysarthria. For severe dysarthria, all panel groups presented mean values 
associated with low volume, with the neurologists the most critical. 
In 
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GP SLTs Neurologists Relatives PD patients
Without dysarthria 2,80 3,00 3,20 2,90 2,71
Mild 2,30 2,63 2,53 2,30 2,06
Moderate 2,08 2,30 2,05 2,13 1,65
Severe 1,10 0,85 0,80 1,00 0,65
0,00
0,50
1,00
1,50
2,00
2,50
3,00
3,50
Without dysarthria Mild Moderate Severe
Figure 8: Audio-perceptive analysis of conversation parameter discourse comprehensibility per level of dysarthria and 
by all panel groups 
terms of articulation, all -panel members presented mean values pointing to good 
articulation for control participants, neurologists had the highest with a mean of 3.1 and 
PD patients the lowest at 2.6. All groups had mean values corresponding to 
normal/adequate articulation for mild dysarthria, with the neurologists the most critical 
and SLTs the least critical. For moderate dysarthria, only two groups had mean values 
that did not correspond to normal/adequate articulation but were associated with bad 
articulation: neurologists and PD patients. For severe dysarthria, all jury groups had 
mean values associated with bad articulation, neurologists were the most critical group 
and the general population the least. Data are presented in figure 7. 
 
 
 
 
 
 
 
 
 
 
 
 
Relative to discourse comprehensibility, looking at the data presented in figure 8 it is 
possible to notice that only severe dysarthria had mean values from all panel groups that 
were associated with difficulty understanding speech, with PD patients the most critical 
group. The control participant had mean values from all groups that corresponded with 
discourse comprehensibility, and SLTs and neurologists both considered mild dysarthria 
as easy to understand. The other groups considered mild dysarthria as normal/adequate 
to understand and all groups also considered moderate dysarthria as being 
normal/adequate to understand.  
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Correlation between discourse comprehensibility and the other parameters 
 
Discourse comprehensibility is a parameter that corresponds to the perception of 
speech intelligibility of each participant. Because this was the main focus of the study, 
the possibility of a correlation between this parameter and other parameters was 
investigated, namely velocity, intensity, and articulation.  For this, Spearman’s 
correlation was performed. Between discourse comprehensibility and articulation there 
was a strong uphill positive linear relationship that was statistically significant ((0.01 
level [rs = +0.7]). Between discourse comprehensibility and intensity there was a 
moderate uphill positive relationship that was statistically significant (0.01 level [rs = 
+0.5]). Between discourse comprehensibility and velocity there was a weak uphill 
positive linear relationship that was a statistically significant (0.01 level [rs = +0.3]).  
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DISCUSSION   
 
The hypothesis of the current study main was verified and overall differences in the hit 
percentage of dysarthric speech between speakers with dysarthria, SLTs, naive listeners, 
relatives and neurologists, for words and sentences was assessed. 
For orthographic transcription of words, neurologists hadthe highest hit percentage 
with 70.4% followed by SLTs with 66.8%, relatives with 60.6%, general population 
with 60.2%, and PD patients with56.2% . Pairwise comparisons showed significant 
differences between neurologists and all the other groups, except for SLTs, in the 
medians of the total words correctly annotated. There were also significant differences 
between SLTs and the general population. These results may be justified by the 
expertise of the clinicians, especially neurologists who have many years of direct 
experience working with PD. Despite years of experience working with adults and with 
different types of dysarthria, one of the main inclusion criteria for SLTs for this study 
was that they did not have direct experience working daily with PD. This may justify 
the difference between total scores of correctly transcribed words between the two 
groups of clinicians and point to a need for specialization and for evidence-based 
expertise. Some studies affirm that familiarizing the listener with the type of dysarthria 
has been found to produce intelligibility benefits68,70,81 and Kreiman at al. defend that 
clinical training and experience might influence speech perception.82 These studies 
support the results presented here, where clinicians who knew in advance the type of 
dysarthria associated with PD, and work with dysarthric patients in their clinical 
practice, presented greater percentages of correctness. In other studies, speech-language 
pathologists provided significantly higher intelligibility scores for the speakers with 
dysarthria.83 The published literature also shows that clinicians who have experience 
with disordered speakers obtained higher transcription scores than inexperienced 
listeners,84 which is in agreement with the findings in this study. As far as PD patients 
are concerned, their scores were the lowest. The published literature states that 
individuals with dysarthria may perceive their speech differently to those without 
dysarthria67,85 and suggest that PD patients lack insight into their speech difficulties63. 
However, this is about PD patients listening to their own speech and not about PD 
patients’ perceptions of dysarthric speech by other PD patients. A literature review about 
perception of speech by individuals with PD provided evidence that PD patients have a 
deficit in the perception of loudness and other speech dimensions such as pitch and 
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duration, deficits in perception of emotions in speech and prosody, as a result of general 
cognitive impairment.
60
 All of this may justify the lower scores of PD patients in the 
tasks related to the intelligibility of words and sentences, taking also into account that 
MoCA scores of the group showed some cognitive impairment. 
For orthographic transcription of sentences, neurologists were those who had the 
highest hit percentage with 75% followed by SLTs with 73%, the general population 
with 67.8%, relatives with, 66.4%, and PD patients with 61.2%. There are significant 
median differences between SLTs and PD patients, neurologists and relatives, and 
neurologists and PD patients. Again, the clinicians were the participants with the highest 
scores in the intelligibility tasks and, of note both clinicians groups had significant 
differences with the PD patient group, the group with the lowest scores. One result that 
was not expected was that the general population, a group with no contact with PD 
patients, had higher scores than relatives, a group of participants with daily contact with 
PD patients. Although the difference were not very large this fact goes against what was 
initially proposed, that listeners with greater interaction with PD would have higher 
scores in the intelligibility tasks. However, there are studies that show no difference 
when a listener was familiarized with disarthric speech,65,67 and there are studies that 
have reported that prior familiarization with a specific speaker led to increased 
intelligibility scores68,70 but the relatives group in this study were not familiar to the 
actual patients recorded in the audio-files, so familiarization cannot be considered with 
a specific speaker.  
Familiarity with stimuli certainly produced higher scores than those not familiar.65 In 
this study, none of the panel members was familiar with the stimuli so this was a 
controlled parameter in order to ensure more functional measures of intelligibility. 
Comparing the hit percentages between words and sentences, there were higher values 
in intelligibility of sentences task for all groups except for the control one who had 
higher values in intelligibility of words task. The literature states that words are harder 
to understand in isolation than in a sentence because of absence of context.65,66 Studies 
show that semantic predictability dramatically affects a listener’s ability to understand 
dysarthric speech, with sentences that are more predictable resulting in higher 
intelligibility scores.67 For the control participant, sentences seemed to be difficult to 
understand and this can be justified by the listeners’ sensitivity to normal age-related 
changes in speech, perhaps especially changes related to voice or prosody as stated in a 
study from Sussman and Tjaden.86 In this study, the scores of correct transcription of 
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sentences for severe dysarthria approached 50% for all groups, with exception of PD 
patients. This seems a high hit percentage taking into account the severity of dysarthria. 
In real life situations there are other cues that help in speech intelligibility like visual 
cues and so, these cues could help obtain  50% intelligibility, which seems unrealistic. 
However, there are two studies that report that for speakers with severe dysarthria, 
intelligibility differences between auditory and auditory–visual presentation modes are 
not clinically meaningful (up to 3% difference).67,69 Also there are contextual variables 
that may make intelligibility of speech more difficult, such as ambient noise. This is 
corroborated by Wild et al. who highlights that conversations in everyday life are often 
made more challenging by poor listening conditions that degrade speech (e.g., electronic 
transmission, background noise) or by tasks that distract us from our conversational 
partner.76 Another aspect to take into account is that people with PD can raise their 
speech performance when concentrating in short bursts when it matters, situations 
which may theoretically include research assessments.87 This leads us to believe that 
this 50% represents a very high sentence intelligibility value for severe dysarthria. This 
is something to take into account because intelligibility interferes with important 
decisions like discharge or decision-making on alternative communication systems, 
especially in severe dysarthria cases.  
Something that was not expected and can be observed when comparing the correct 
percentages of all groups for orthographic transcription of words between mild and 
moderate dysarthria, is that for mild dysarthria, all groups scored less. The same 
happened for the orthographic transcription of sentences for the general population and 
relatives groups, who scored higher in moderate dysarthria than in mild dysarthria. This 
may be influenced by the stimuli, i.e., the type of words or sentences selected for each 
level of dysarthria. Considering that for example, there are some errors that may not 
change the general meaning of the phrase or word, for more specific results a further 
analysis of the type of error is necessary.  
In the present study we proposed to determine if SLTs have a higher inter-rater 
reliability in their ratings of dysarthric speech when compared with naive listeners and 
thos was verified, but, in general, all groups showed a high inter-rater reliability. 
The audio-perceptive analysis was based on conversation samples. This choice is 
supported by the literature as it shows identification of perceptual features may be 
maximized through use of a conversational tasks.88 
With regards to velocity, only moderate and severe dysarthria were scored with slow 
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velocity correspondent values. A study from Nishio and Niimi in 2001 showed that 
speakers with flaccid and hypokinetic dysarthria displayed near normal articulation rates 
compared to the rates used by speakers with other types of dysarthria.89 One thing to 
note is that SLTs were much more critical of the control participant’s conversation that 
the other levels of dysarthria. This was also noted by Dagenais et al. who reported  that 
SLTs were more critical of the normal speakers.83 This also make sense since SLTs have 
knowledge about other variables that influence the perception of speech velocity – for 
example, louder speech is perceived faster than softer speech; small F0 variation is 
perceived as faster speech than higher speaking F0.53 There are also studies that showed 
that clear speech is characterized by a slower speech rate90 which supported the lowest 
mean scores from SLTs.  
With regards to intensity, the major reported differences were between the normal 
speaker and severe dysarthric speakers and this is supported by literature that states that 
the rigidity and bradykinesia typical of PD interfere with muscle movements including 
vocal cord movements that are incomplete, leading to glottal incompetence and 
hypophonation, which are expected to worsen with the progression of the 
disease.30,36,55,58-59 Between normal, mild and moderate dysarthria there were not many 
differences reported. All groups scored mean values that corresponded to 
normal/adequate intensity, except for severe dysarthria that was associated with low 
intensity or volume. Interestingly, PD patients showed higher differences in mean scores 
between the different levels of dysarthria compared to other groups. The published 
literature shows that patients with PD have impaired self-perception of speech volume. 
This seems to be associated with abnormally high order representations of sensory 
events and not with auditory deficits (something that was part of our exclusion 
criteria).91 In this study this did not seem to happen with the perception of speech 
volume of other patients making sense if that is not an association with hearing loss and 
PD.  However, there is one study that reports that PD patients perceived interlocutor 
speech volumes to be louder by patients than control subjects especially at further 
distances.92 
Regarding articulation, there was clearly a tendency of lower mean values as 
dysarthria worsens,, by all groups and despite of the differences between groups. This 
finding is confirmed by Skodda et al. who reported that vowel articulation in 
Parkinsonian speakers exhibited a significant deterioration which was not observed in 
the control group and therefore can be interpreted as a symptom of disease 
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progression.50 Articulation seems to be a parameter that everyone can comment on more 
easily, even non-clinical groups. Articulation defects seem to be easier to identify by all 
groups, compared with other parameters such as intensity and speed and are usually 
mentioned more in the clinical context by relatives and patients themselves. This could 
be justified by the tendency of listeners to readily register when someone has speech 
that draws attention to itself, when pronunciation deviates from some notion of 
‘normal’.62 Miller et al. mentioned that even when intelligibility is not particularly 
affected, altered sound production may be linked with marked psychosocial 
consequences for the speaker.62  
For the last parameter, discourse comprehensibility, we also observed a tendency of 
lower mean values with worsening dysarthria severity, by all groups despite of the 
differences between groups. This parameter refers to intelligibility of speech. Its 
correlation to with disease severity is not well described. There is presently no 
consensus as to which perceptual constructs capture the impact of speech impairment 
secondary to dysarthria.86 However, Weismer et al. have indicated it as been related to 
severity of dysarthria in research that indicated no significant difference in scaled 
estimates of intelligibility or severity93 being in agreement with the results of the present 
study.  
Because the means of the scores in the articulation and discourse comprehensibility 
parameters followed an expected tendency, a positive correlation between these two 
parameters was expected and  a strong positive statistically significant correlation was 
observed. On the other hand, the correlation with intensity was moderate, and the 
correlation with speech rate or velocity was weak.  
The results seems to confirm the expertise of the experts who classified the level of 
dysarthria of the patients selected for the study sample. 
This study had certain limitations that must be highlighted. For relatives and general 
population groups cognitive status with the MoCA was not verified and this may be a 
variable to consider as with advancing age there is a greater probability of cognitive 
deficit and these groups had a minimum of 55 years of age. For sentence intelligibility 
task analysis, the type of error of the phrase and whether the type of error changed or 
not the meaning of the phrase was not taken into account. In 2008, Hustad described 
problems with the binomial scoring used in sentence transcription intelligibility tasks.34  
Specifically, words are scored as either correct or incorrect relative to the target word, a 
percent correct score gives equal weight to all word classes such that scores are not 
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transparent as to whether the listener was able to decipher the meaning or intent of the 
spoken message.34 At the end, comprehension scores were consistently better than 
intelligibility scores for all dysarthria severity groups.34 For future studies it will 
interesting to make this difference between intelligibility and comprehension, taking 
into account the type of errors in the orthographic transcription tasks. It made sense to 
correlate the results of audio-perceptive analyses of conversation with dysarthria 
severity, but, the N of audio-files per level of dysarthria were reduced and it is not 
possible to draw conclusions from this data. It will be interesting to continue this study 
with a higher number of participants. Another aspect that seems to deserve more 
attention is the correlation between articulation and intelligibility of speech by taking 
into account that articulation is more easily noticed and articulation defects seems to be 
more evident for all groups of interlocutors of PD patients. 
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CONCLUSIVE REMARKS 
 
The level of speech intelligibility varies according to the listeners, and the professional 
groups working with dysarthria on a daily basis are more likely to understand the 
discourse of PD patients, even when compared with the family members that spend the 
most time with patients. Articulation defects are more easily perceived by any 
interlocutor compared to the intensity or speed of discourse, and the articulation seems 
to be correlated with speech intelligibility. The perception of both is more difficult as 
the degree of severity of dysarthria evolves, and this for all groups of interlocutors.  
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Annex I – Information sheet 
 
Folha de Informação para os participantes a integrar o júri 
 
Título do projeto de investigação 
Análise áudio-percetiva da disartria associada à Doença de Parkinson por diferentes 
profissionais de saúde, doentes, familiares e população em geral. 
 
Objetivo do estudo 
O objetivo desta investigação centra-se em determinar se o mesmo discurso disártrico 
associado à Doença de Parkinson é entendido da mesma forma por diferentes tipos de 
interlocutores, com maior ou menor contacto com a doença. Principal questão de 
investigação: existem diferenças na inteligibilidade do discurso disártrico para 
diferentes interlocutores, nomeadamente: terapeutas da fala, neurologistas, familiares de 
doentes de Parkinson, os próprios doentes ou para a população em geral (sem contacto 
com a doença)? 
 
Procedimento 
Será elaborado um corpus com gravações de amostras de fala por parte de pessoas 
com a Doença de Parkinson e sem a doença – palavras, frases, conversa – e será reunido 
um júri que irá ouvir as gravações, anotar ortograficamente as palavras e as frases e 
realizar uma análise percetiva a um excerto de conversa, classificando cada amostra 
com recurso a uma escala de 0 a 5 no que diz respeito a volume, articulação, 
inteligibilidade do discurso e velocidade de fala.  
 
Possíveis benefícios para os participantes 
Se concordar em participar, não terá nenhum benefício clínico direto. Contudo, a sua 
participação poderá contribuir para o aumento do conhecimento sobre a inteligibilidade 
do discurso na Doença de Parkinson, o que poderá beneficiar os doentes ou terceiros no 
futuro. Não receberá nenhuma compensação económica pela sua participação neste 
estudo. 
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Riscos físicos previsíveis 
Não está previsto qualquer risco decorrente da participação neste estudo.  
 
Participação voluntária e direitos de abandono 
Se concordar em participar, a qualquer momento pode desistir e solicitar que os dados 
recolhidos neste estudo sejam eliminados sem qualquer consequência para si. 
 
Utilização dos dados 
Se assinar este consentimento, dará permissão ao investigador principal envolvido 
neste estudo, aos seus orientadores e à equipa do JJ Ferreira Lab, Instituto de Medicina 
Molecular, para que utilizem informações demográficas, adequadamente anonimizadas. 
A informação usada neste estudo, e que poderá ser divulgada, inclui dados que serão 
anonimizados, de forma a que não seja possível associar a identidade às gravações ou 
aos dados demográficos. A futura apresentação e publicação dos resultados do estudo 
respeitará sempre a confidencialidade dos dados e o anonimato dos participantes. 
 
Contatos  
Poderá contactar a investigadora principal do estudo, Mestranda Joana Carvalho para 
responder a qualquer dúvida que tenha relativamente ao estudo e à sua participação no 
mesmo.  
Contacto telefónico: 927854139 
Email: joana.margarida.cr@gmail.com 
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Annex II – Informed Consent 
 
DECLARAÇÃO DE CONSENTIMENTO INFORMADO 
 
Título do projeto de investigação 
Análise áudio-percetiva da disartria associada à Doença de Parkinson por diferentes 
profissionais de saúde, doentes, familiares e população em geral. 
 
Eu expliquei detalhadamente este estudo ao participante. Como investigadora deste 
estudo, eu expliquei os objetivos, os procedimentos, os benefícios e os riscos que estão 
envolvidos neste estudo. Todas as perguntas que foram levantadas foram respondidas 
para garantir a compreensão do participante.  
 
Assinatura da pessoa  que                 Nome da pessoa que                                     Data    
obteve o consentimento                    obteve o consentimento  
 
 
Eu abaixo assinado 
(a)........................................................................................................., li este formulário 
de consentimento e fui informado sobre o objetivo deste estudo, os procedimentos, os 
possíveis benefícios e riscos, e aceito participar de livre e espontânea vontade.  Recebi 
uma cópia assinada deste consentimento. Foi-me dada a oportunidade de fazer 
perguntas antes de assinar, e foi-me dito que posso fazer outras perguntas a qualquer 
momento. Eu concordei em participar neste estudo de forma voluntária. Concordo em 
cooperar com a investigadora principal do estudo, Mestranda Joana Carvalho e com os 
seus orientadores, Prof. Doutor Joaquim Ferreira e Prof. Doutora Isabel Guimarães. 
Foi-me explicado que : 
Sou livre para sair do estudo a qualquer momento sem necessidade de justificar a minha 
decisão. 
Os dados a meu respeito serão estritamente confidenciais. Posso, a qualquer momento, 
exercer o meu direito de acesso, retificação e oposição. 
A publicação dos resultados da investigação respeitará o meu direito ao anonimato. 
 
O meu consentimento não isenta os organizadores do estudo das suas responsabilidades. 
São legalmente mantidos todos os meus direitos. 
 
 
Assinatura do Participante                Nome do Participante               Data 
 
 
 
 
Foi entregue um duplicado deste documento ao participante. 
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Annex III – CRF 
 
Análise áudio-percetiva da disartria associada à Doença de Parkinson por 
diferentes profissionais de saúde, doentes, familiares e população em geral. 
 
Investigadora principal: Joana Carvalho 
 
 
CRF - Case Report Form - Avaliador 
 
 
 
Projeto desenvolvido no âmbito do Mestrado em Neurociências da Faculdade de Medicina 
da Universidade de Lisboa 
 
Orientador: Prof. Doutor Joaquim Ferreira 
Co-Orientadora: Prof. Doutor Isabel Guimarães 
 
Locais onde decorre o estudo: 
    - Laboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina da 
Universidade de Lisboa (FMUL) 
    - CNS - Campus Neurológico Sénior, Torres Vedras 
 
 
Aprovação pela Comissão de Ética Centro Hospitalar Lisboa Norte/ Faculdade de 
Medicina da Universidade de Lisboa, Julho 2016 
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1. Critérios de Inclusão 
 
População em geral  
 > 55 anos                                                                           Sim            Não  
 Sem qualquer contacto regular com pessoas com doença de Parkinson, 
familiares ou amigos, ou qualquer conhecimento das alterações vocais associadas à 
doença 
       Sim            Não  
 
Familiares de pessoas com doença de Parkinson  
 > 55 anos                                                                                 Sim            Não  
 1º ou 2º grau : _________                                                       Sim            Não 
 
 Com contacto diário com a pessoa com Doença de Parkinson 
            Sim            Não 
 
 
Pessoas com Doença de Parkinson 
 > 55 anos                                                                                  Sim            Não 
 
 > 3 anos de diagnóstico                                                            Sim            Não 
 
 Sem declínio cognitivo com impacto na participação do presente estudo 
(Moca>=18)                                                                                         Sim            Não 
 
 
Médicos neurologistas  
 > 5 anos de experiência no seguimento de pessoas com a Doença de Parkinson 
Sim            Não  
 
Terapeutas da fala  
 Com experiência de trabalho com adultos                               Sim            Não 
 especificar área de atuação :_____________________ 
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 Sem experiência na avaliação ou tratamento de pessoas com a Doença de 
Parkinson                                                                                              Sim            Não 
 
 
 
 
 
2. Informação para consentimento informado 
 
O consentimento informado escrito deve ser obtido antes do início de qualquer 
procedimento referente ao estudo. 
 
O consentimento informado foi obtido antes de qualquer avaliação? Sim    Não   
O participante assinou de forma voluntária o consentimento, antes de participar. Sim   Não  
O consentimento informado foi assinado pelo participante e investigador? Sim    Não  
Data da obtenção do consentimento: __/__/____ 
Razões para não participar do 
estudo:______________________________________________ 
- Não cumpre os critérios de inclusão  Especificar:  
- Outras razões: ______________________________________________________________ 
 
3. Dados demográficos 
 
GRUPO 
Familiar □ 
Pessoas com Doença de Parkinson □ 
Terapeuta da Fala □ 
Neurologista □ 
População em geral □ 
 
Data de nascimento: ____/____/__________ Idade:  ____________ 
Naturalidade: ____________________________   Local de residência: 
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__________________    Género: F   M   
Para além do português fala outras línguas?  
1 Inglês        2 Francês         3 Espanhol       4 Outras: __________________________ 
Escolaridade: __________________________________________________________ 
Profissão: _____________________________________________________________ 
 
 
*No caso de ser neurologista, quantos anos de experiência tem com pessoas com a 
Doença de Parkinson? ____ 
**No caso de ser Terapeuta da Fala, quantos anos de experiência de trabalho com 
adultos? ____ 
 
Formação Musical: Sim / Não 
 Se sim, especificar:_________________________________________________ 
Hábitos de leitura: Sim / Não    
Se sim, com que frequência?   
 □ Diariamente       □  Semanalmente        □  Mensalmente 
Contacto com pessoas com Doença de Parkinson: Sim / Não 
Se sim: quantos dias por semana?________ Quantas horas por dia? ________  
Em que contexto? __________________________________________________ 
Grau de parentesco ou relação com o doente de Parkinson __________________ 
Conhecimento de sinais e sintomas associados à Doença de Parkinson : Sim / Não 
Se sim, quais? 
__________________________________________________________ 
 
4. Historial médico 
 
***No caso de ser doente de Parkinson: 
Data do diagnóstico: __/__/____    Data dos primeiros sintomas: __/__/____  
Problemas clínicos atuais:  
Flutuações motoras □ Discinésias □ Freezing da marcha □ Delírio/ Alucinações □  
Sintomas vocais: 
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 Fala arrastada □ Volume de fala diminuído □ Rouquidão □  
Outros (especificar): _____________________  
 
História clínica de défice auditivo diagnosticado? Sim / Não 
 Se sim, quando?_____________________ 
Utiliza prótese (s) auditivas? Sim / Não 
 Se sim, em que ouvido? OD □       OE □ 
 Há quantos anos? ________ 
 Estão bem ajustadas? Sim / Não 
Dificuldade auditiva percecionada pelo próprio? Sim / Não 
 Se sim: □ OD  0-1-2-3-4-5                    □ OE    0-1-2-3-4-5 
Neste momento tem alguma outra condição médica (ex: constipação, alergias) que 
considera afetar-lhe a audição? Sim / Não 
 Se sim, especificar: ____________________________ 
História clínica de défice cognitivo diagnosticado: atenção, memória, concentração, 
resolução de problemas? Sim / Não 
 Se sim, quando?_____________________ 
Alterações cognitivas percecionadas pelo próprio? Sim / Não  
 Se sim, especificar:______________________________________________  
Medicação atual: 
Medicação Dosagem Data de início 
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Análise áudio-percetiva da disartria associada à Doença de Parkinson por 
diferentes profissionais de saúde, doentes, familiares e população em geral. 
 
Investigadora principal: Joana Carvalho 
 
 
 
 
CRF - Case Report Form - Juri 
 
 
 
Projeto desenvolvido no âmbito do Mestrado em Neurociências da Faculdade de Medicina 
da Universidade de Lisboa 
 
Orientador: Prof. Doutor Joaquim Ferreira 
Co-Orientadora: Prof. Doutora Isabel Guimarães 
 
Locais onde decorre o estudo: 
    - Laboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina da 
Universidade de Lisboa (FMUL) 
    - CNS - Campus Neurológico Sénior, Torres Vedras 
 
 
 
 
Aprovação pela Comissão de Ética Centro Hospitalar Lisboa Norte/ Faculdade de 
Medicina da Universidade de  Lisboa, Julho 2016 
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Grupo 
Familiar □ 
Doente de Parkinson □ 
Terapeuta da Fala □ 
Neurologista □ 
População Geral □ 
 
A disartria representa uma alteração da fala e está presente em 70%-100% das pessoas com 
Doença de Parkinson e a inteligibilidade da fala, a facilidade com que um ouvinte é capaz de 
descodificar as declarações de um falante é um dos principais critérios utilizados para a 
avaliação da gravidade da disartria. 
Este é um estudo que tem por objetivo perceber se a fala alterada (disartria) das 
pessoas com Doença de Parkinson é compreendida de forma diferente, com mais ou 
menos facilidade, por diferentes interlocutores. Agradeço desde já a sua participação. 
 
1. A primeira parte consiste na anotação ortográfica de palavras. 
De seguida irá ouvir uma série de palavras produzidas por pessoas com a Doença de 
Parkinson e sem Doença de Parkinson. Coloque os auriculares. Cada palavra será 
reproduzida apenas uma vez. Registe exatamente o que ouve em letras maiúsculas. Se 
não compreender passe à frente. Entre cada palavra terá uma pausa para escrever. 
Quando precisar de uma pausa maior por qualquer motivo (ex: cansaço) basta pedir à 
investigadora responsável. 
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Anotação ortográfica de palavras: 
1.  26. 
2.  27. 
3.  28. 
4.  29. 
5.  30. 
6.  31. 
7.  32. 
8.  33. 
9.  34. 
10.  35. 
11.  36. 
12.  37. 
13.  38. 
14.  39. 
15.  40. 
16.  41. 
17.  42. 
18.  43. 
19.  44. 
20.  45. 
21.  46. 
22.  47. 
23.  48. 
24.  49. 
25.  50. 
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2. A segunda parte consiste na anotação ortográfica de frases. 
De seguida irá ouvir uma série de frases produzidas por pessoas com a Doença de 
Parkinson e sem Doença de Parkinson. Coloque os auriculares. Cada frase será 
reproduzida apenas uma vez. Registe exatamente o que ouve em letras maiúsculas. Se 
não compreender passe à frase seguinte. Entre cada frase terá uma pausa para escrever. 
Quando precisar de uma pausa maior por qualquer motivo (ex: cansaço) basta pedir à 
investigadora responsável. 
Anotação ortográfica de frases: 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
13. 
14. 
15. 
16. 
17. 
18. 
19. 
20. 
21. 
22. 
23. 
24. 
25. 
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26. 
27. 
28. 
29. 
30. 
31. 
32. 
33. 
34. 
35. 
36. 
37. 
38. 
39. 
40. 
41. 
42. 
43. 
44. 
45. 
46. 
47. 
48. 
49. 
50. 
 
  
75 
 
 
3. A terceira parte consiste numa avaliação percetiva de excertos de 
conversa. 
Terá de classificar a fala de cada pessoa no que diz respeito a intensidade, velocidade 
de fala, articulação e facilidade de compreensão do discurso. De seguida ser-lhe-ão 
apresentados alguns conceitos e uma escala associada a cada um deles. 
 
Velocidade de fala: ritmo que cada indivíduo utiliza no seu discurso (ex: lento, 
rápido).  
 
Intensidade/ loudness (volume): A intensidade é propriedade física do sinal acústico; 
pode ser medida em decibéis (dB). Loudness é a sensação subjetiva de magnitude de um 
som que permite avaliar o nível de intensidade desse som. Por ex: ‘Estás a falar muito 
alto’; ‘ fala mais baixo, não faças barulho’. Uma intensidade adequada tem variações 
adequadas a uma conversa. 
 
Articulação/ Dicção: processo de produção e utilização dos sons da fala de uma 
determinada comunidade linguística; diz respeito à forma como a pessoa articula os 
sons da fala (pode ser de uma forma clara – ex: boa dicção; menos clara – má dicção). 
Uma articulação adequada considera-se uma articulação com precisão dos sons do 
Português. Uma má articulação caracteriza-se por imprecisões, trocas ou omissões de 
sons, tornando difícil o que está a dizer. 
 
Facilidade de compreensão do discurso: a aptidão com que um ouvinte é capaz de 
descodificar as declarações de um falante (ex: fácil de compreender, difícil de 
compreender – não por dificuldades do ouvinte como, por exemplo, auditivas, mas pelo 
discurso do falante).  
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De seguida irá ouvir uma série de excertos de conversa. Coloque os auriculares. Cada 
excerto contém 20seg de conversa e será reproduzido apenas uma vez. Registe a sua 
perceção em relação a cada parâmetro descrito anteriormente na escala apropriada, 
marcando uma cruz no local que considera mais apropriado. No caso de achar uma 
categoria variável, como por exemplo, em parte da conversa uma velocidade de fala 
rápida, noutra parte lenta, assinale duas opções. 
 
1. Nesta conversa considero 
Velocidade de fala Muito lento □ Lento □ Normal/ Adequada 
□ 
Rápido 
□ 
Muito rápido 
□ 
Intensidade Muito baixo 
□ 
Baixo □ Normal/ Adequada 
□ 
Alto □ Muito alto □ 
Articulação/ 
Dicção 
Muito má □ Má □ Normal/ Adequada 
□ 
Boa □ Muito boa □ 
Compreensão do 
discurso 
Muito difícil 
□ 
Difícil □ Normal/ Adequada 
□ 
Fácil □ Muito fácil □ 
 
2. Nesta conversa considero 
Velocidade de fala Muito lento □ Lento □ Normal/ Adequada 
□ 
Rápido 
□ 
Muito rápido 
□ 
Intensidade Muito baixo 
□ 
Baixo □ Normal/ Adequada 
□ 
Alto □ Muito alto □ 
Articulação/ 
Dicção 
Muito má □ Má □ Normal/ Adequada 
□ 
Boa □ Muito boa □ 
Compreensão do 
discurso 
Muito difícil 
□ 
Difícil □ Normal/ Adequada 
□ 
Fácil □ Muito fácil □ 
 
3. Nesta conversa considero 
Velocidade de fala Muito lento □ Lento □ Normal/ Adequada 
□ 
Rápido 
□ 
Muito rápido 
□ 
Intensidade Muito baixo 
□ 
Baixo □ Normal/ Adequada 
□ 
Alto □ Muito alto □ 
Articulação/ 
Dicção 
Muito má □ Má □ Normal/ Adequada 
□ 
Boa □ Muito boa □ 
Compreensão do 
discurso 
Muito difícil 
□ 
Difícil □ Normal/ Adequada 
□ 
Fácil □ Muito fácil □ 
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4. Nesta conversa considero 
Velocidade de fala Muito lento □ Lento □ Normal/ Adequada 
□ 
Rápido 
□ 
Muito rápido 
□ 
Intensidade Muito baixo 
□ 
Baixo □ Normal/ Adequada 
□ 
Alto □ Muito alto □ 
Articulação/ 
Dicção 
Muito má □ Má □ Normal/ Adequada 
□ 
Boa □ Muito boa □ 
Compreensão do 
discurso 
Muito difícil 
□ 
Difícil □ Normal/ Adequada 
□ 
Fácil □ Muito fácil □ 
 
5. Nesta conversa considero 
Velocidade de fala Muito lento □ Lento □ Normal/ Adequada 
□ 
Rápido 
□ 
Muito rápido 
□ 
Intensidade Muito baixo 
□ 
Baixo □ Normal/ Adequada 
□ 
Alto □ Muito alto □ 
Articulação/ 
Dicção 
Muito má □ Má □ Normal/ Adequada 
□ 
Boa □ Muito boa □ 
Compreensão do 
discurso 
Muito difícil 
□ 
Difícil □ Normal/ Adequada 
□ 
Fácil □ Muito fácil □ 
 
6. Nesta conversa considero 
Velocidade de fala Muito lento □ Lento □ Normal/ Adequada 
□ 
Rápido 
□ 
Muito rápido 
□ 
Intensidade Muito baixo 
□ 
Baixo □ Normal/ Adequada 
□ 
Alto □ Muito alto □ 
Articulação/ 
Dicção 
Muito má □ Má □ Normal/ Adequada 
□ 
Boa □ Muito boa □ 
Compreensão do 
discurso 
Muito difícil 
□ 
Difícil □ Normal/ Adequada 
□ 
Fácil □ Muito fácil □ 
 
7. Nesta conversa considero 
Velocidade de fala Muito lento □ Lento □ Normal/ Adequada 
□ 
Rápido 
□ 
Muito rápido 
□ 
Intensidade Muito baixo 
□ 
Baixo □ Normal/ Adequada 
□ 
Alto □ Muito alto □ 
Articulação/ 
Dicção 
Muito má □ Má □ Normal/ Adequada 
□ 
Boa □ Muito boa □ 
Compreensão do 
discurso 
Muito difícil 
□ 
Difícil □ Normal/ Adequada 
□ 
Fácil □ Muito fácil □ 
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8. Nesta conversa considero 
Velocidade de fala Muito lento □ Lento □ Normal/ Adequada 
□ 
Rápido 
□ 
Muito rápido 
□ 
Intensidade Muito baixo 
□ 
Baixo □ Normal/ Adequada 
□ 
Alto □ Muito alto □ 
Articulação/ 
Dicção 
Muito má □ Má □ Normal/ Adequada 
□ 
Boa □ Muito boa □ 
Compreensão do 
discurso 
Muito difícil 
□ 
Difícil □ Normal/ Adequada 
□ 
Fácil □ Muito fácil □ 
 
9. Nesta conversa considero 
Velocidade de fala Muito lento □ Lento □ Normal/ Adequada 
□ 
Rápido 
□ 
Muito rápido 
□ 
Intensidade Muito baixo 
□ 
Baixo □ Normal/ Adequada 
□ 
Alto □ Muito alto □ 
Articulação/ 
Dicção 
Muito má □ Má □ Normal/ Adequada 
□ 
Boa □ Muito boa □ 
Compreensão do 
discurso 
Muito difícil 
□ 
Difícil □ Normal/ Adequada 
□ 
Fácil □ Muito fácil □ 
 
10. Nesta conversa considero 
Velocidade de fala Muito lento □ Lento □ Normal/ Adequada 
□ 
Rápido 
□ 
Muito rápido 
□ 
Intensidade Muito baixo 
□ 
Baixo □ Normal/ Adequada 
□ 
Alto □ Muito alto □ 
Articulação/ 
Dicção 
Muito má □ Má □ Normal/ Adequada 
□ 
Boa □ Muito boa □ 
Compreensão do 
discurso 
Muito difícil 
□ 
Difícil □ Normal/ Adequada 
□ 
Fácil □ Muito fácil □ 
 
 
 
 
